论文部分内容阅读
目的:探讨消融联合化疗和靶向药物治疗老年非小细胞肺癌的临床治疗效果。方法:选择2013年10月至2015年10月在我院接受治疗的老年非小细胞肺癌患者98例,随机分为实验组和对照组,每组各49例。对照组患者采用消融联合化疗的方式治疗,实验组患者采用消融联合化疗和靶向药物的方式治疗,对比两组患者的临床治疗效果。结果:实验组患者治疗后完全缓解14例,治疗有效率为63.3%;对照组患者治疗后完全缓解7例,治疗有效率为47.0%;实验组患者的治疗效果明显好于对照组,P<0.05,数据差异具有统计学意义。结论:消融联合化疗和靶向药物对老年非小细胞肺癌的治疗效果更加理想。
Objective: To investigate the clinical effect of ablation combined with chemotherapy and targeted drugs in the treatment of elderly non-small cell lung cancer. Methods: A total of 98 elderly patients with non-small cell lung cancer treated in our hospital from October 2013 to October 2015 were randomly divided into experimental group and control group, with 49 cases in each group. Patients in the control group were treated with ablation combined with chemotherapy. Patients in the experimental group were treated with ablation combined with chemotherapy and targeted drugs, and the clinical effects were compared between the two groups. Results: In the experimental group, 14 cases were completely relieved after treatment, and the effective rate was 63.3%. In the control group, 7 cases were completely relieved after treatment and the effective rate was 47.0%. The therapeutic effect of the experimental group was significantly better than that of the control group (P < 0.05, the data difference was statistically significant. Conclusion: The ablation combined with chemotherapy and targeted drugs is more ideal for the treatment of elderly non-small cell lung cancer.